Nuvation Bio Inc.
Clinical trials sponsored by Nuvation Bio Inc., explained in plain language.
-
Cancer drug trial halted early: what happened with AB-106?
Disease control TerminatedThis study tested a daily pill called AB-106 in people with advanced solid tumors that have a specific gene change (NTRK fusion). The goal was to see if the drug could shrink tumors. Only 14 people took part before the study was stopped early. The drug was given until the cancer …
Phase: PHASE2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 17, 2026 05:47 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested a new drug called NUV-868, alone or combined with other cancer drugs (olaparib or enzalutamide), in people with advanced solid tumors like ovarian, pancreatic, prostate, or breast cancer. The main goals were to check safety and find the right dose. The study was…
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC